UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 12, 2022 4:30 P.M.

Form:	S-3
CIK: 0001840574 Company Name: Verve Therapeutics, Inc. File Number: 333-265996